Advertisement
News
Subscribe to MDT Magazine News

PMA Final Decisions for February 2011

April 6, 2011 8:38 am | by U.S. Food & Drug Administration | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for February 2011.

Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010

April 6, 2011 8:37 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- TriMarkPublications.com cites in its newly published " Medical Imaging Markets" report that global spending on medical imaging equipment exceeded $21 billion in 2010. For more information, visit:...

TOPICS:

United Nations Urged to Ban Mercury in Vaccines

April 6, 2011 8:36 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., April 6, 2011 /PRNewswire-USNewswire/ -- CoMeD – While the United Nations (UN) actively questions the use of vaccines containing a neurotoxic mercury compound, the Coalition for Mercury-Free Drugs (CoMeD), a Maryland-based, non-profit organization, is urging the...

TOPICS:
Advertisement

KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive agreement with AdnaGen, a wholly-owned subsidiary of Alere, Inc., to...

TOPICS:

MIT's Koch Institute to use Roche LightCycler 480 System to Help Advance Cancer Research

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, April 6,  2011 /- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler ® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of...

TOPICS:

Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

MALIBU, Calif., April 6, 2011 /- Cliffside Malibu, one of America's leading drug and alcohol treatment centers, is strongly urging its patients who are currently taking antidepressants not to stop, despite a new study and subsequent media reports that such drugs could raise the risk of...

TOPICS:

An international study in China finds strawberries may slow precancerous growth in the esophagus

April 6, 2011 7:38 am | by EurekAlert | Comments

(Ohio State University Medical Center) Eating strawberries may be a way to help people at risk of esophageal cancer protect themselves from the disease, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer...

TOPICS:

Yervoy (ipilimumab): Risk Evaluation and Mitigation Strategy (REMS) - Severe Immune-Mediated Adverse Reactions

April 6, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

The most common severe reactions include enterocolitis, hepatitis, dermatitis (including toxic epidermal necrolysis), neuropathy, and endocrinopathy.

TOPICS:
Advertisement

FDA Clears Mandometer® for the Treatment of Eating Disorders

April 6, 2011 6:39 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- The U.S. Food and Drug Administration announced on March 31 that it had cleared Mandometer® for the treatment of patients with eating disorders.   Mandometer® is an innovative device that provides biofeedback allowing individuals to monitor their...

TOPICS:

Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results

April 6, 2011 6:37 am | by Bio-Medicine.Org | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., April 6, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ), and Watson Pharmaceuticals, Inc. (NYSE: WPI ), today announced the publication of Phase III PROCHIEVE® (progesterone gel) data in today's online version of Ultrasound in Obstetrics...

TOPICS:

CVS/pharmacy Debuts the "To Your Health" Program in Atlanta Bringing 60 Free Health Screening Events to the Community

April 6, 2011 6:36 am | by Bio-Medicine.Org | Comments

ATLANTA, April 6, 2011 /- CVS/pharmacy, the nation's leading retail pharmacy, brings its "To Your Health" free health screening program to Atlanta on Saturday, April 9. The program will provide free preventive health screenings for Atlanta area residents at 60 events now through November...

TOPICS:

Michael Douglas, Honored Film Star and Throat Cancer Survivor, Encourages Public to Attend Free Local Screenings During Oral, Head & Neck Cancer Awareness Week

April 6, 2011 6:34 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- Academy Award-winning actor and producer Michael Douglas, who is recovering from a battle with throat cancer, is urging Americans to get screened for cancer during the 14th annual Oral, Head & Neck Cancer Awareness Week (OHANCAW), being held nationwide May...

TOPICS:

Caliper Life Sciences Announces Date and Location of its 2011 Annual Meeting of Stockholders

April 6, 2011 6:34 am | by Bio-Medicine.Org | Comments

HOPKINTON, Mass., April 6, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that its 2011 Annual Meeting of Stockholders will be held on June 2, 2011, at 10:00 a.m. local time at its offices located at 68 Elm Street, Hopkinton, Massachusetts.  The record date for...

TOPICS:

Philips to Take Orders for the Ingenia MRI System in the United States

April 6, 2011 6:34 am | by Bio-Medicine.Org | Comments

ANDOVER, Mass., April 6, 2011 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the United States availability of the Ingenia MRI system, the first-ever digital broadband magnetic resonance imaging (MRI) solution. Previously available in Europe, Canada and...

TOPICS:

Cardica Receives Key Patent for Microcutterâ„¢ Surgical Cutting and Stapling Device

April 6, 2011 5:37 am | by Bio-Medicine.Org | Comments

REDWOOD CITY, Calif., April 6, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the company Patent No. 7,918,376 for its proprietary Microcutter™ technology. This patent relates to the articulation of a surgical...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading